Frost & Sullivan Release: The Race is On: Pharmaceutical Companies Compete to Develop Less Toxic More Efficacious Therapies to Combat Breast Cancer

PALO ALTO, Calif.--(BUSINESS WIRE)--The Pharmaceutical / Biotechnology Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the targeted therapies segment of U.S. breast cancer therapeutics market to be held on Tuesday, February 26, 2008 at 12:00 p.m. CST / 1:00 p.m. EST.